Epetraborole
EBO-301
Phase 3 small_molecule terminated
Quick answer
Epetraborole for MAC Lung Disease is a Phase 3 program (small_molecule) at AN2 Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AN2 Therapeutics
- Indication
- MAC Lung Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated